Waters Stock News

MILFORD, Mass. , Nov. 20, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D.

News summary: Newly built 45,000 sq ft facility houses engineering and skilled manufacturing employees at Longbridge Business Park, a specialized hub for science and technology. Waters triples manufacturing footprint while increasing precision machining and metrology capacity to support future growth.

News Summary: waters_connect™ Data Intelligence software provides laboratories with comprehensive business intelligence on their chromatographic data throughout the product development lifecycle, enabling real-time audit readiness and query response, while reducing time spent on audit preparation. Cloud-based software proactively provides visibility into risks that could trigger adverse regulat...

Shares of Waters Corp. (WAT) surged nearly 20% on Friday, delivering the top daily performance in the S&P 500 after the company reported third-quarter sales and earnings that topped analysts' projections.

Following a pair of negative trading sessions, major U.S. equities indexes closed out the week on a strong note, pushing higher on Friday as investors cheered upbeat earnings results from e-commerce and cloud computing behemoth Amazon (AMZN).

Waters Corporation (NYSE:WAT ) Q3 2024 Earnings Conference Call November 1, 2024 8:00 AM ET Company Participants Caspar Tudor – Head of Investor Relations Udit Batra – President and Chief Executive Officer Amol Chaubal – Senior Vice President and Chief Financial Officer Conference Call Participants Tycho Peterson – Jefferies Brandon Couillard – Wells Fargo Puneet Souda – Leerink Partners Vijay ...

Waters Corp raised its annual profit forecast after beating Wall Street estimates for third-quarter profit and revenue on Friday, on improved demand for its products and services used in drug development and research.

Highlights Sales of $740 million exceeded guidance, grew 4% as reported and 4% in constant currency Instruments returned to growth; recurring revenue grew high single-digits in constant currency All reported regions returned to growth in the quarter; sales grew across all end markets, led by Pharma & Industrial GAAP EPS of $2.71 and non-GAAP EPS of $2.93 significantly exceeded guidance, led by ...